Irbesartan Vocate

Irbesartan, the active ingredient in Irbesartan Vocate, is an Angiotensin II receptor blocker (ARB) presented as an oral tablet for oral use. It is employed to manage high blood pressure and to protect kidney function in patients with diabetic nephropathy. It is indicated for adult patients requiring long‑term blood pressure control and renal protection.

GNH USA supplies Irbesartan Vocate as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to stringent quality standards and regulatory requirements.

Irbesartan acts on the renin‑angiotensin‑aldosterone system to lower blood pressure and protect renal function. - Hypertension: reduces systolic and diastolic blood pressure in adult patients. - Diabetic nephropathy: slows progression of kidney damage associated with diabetes. - Proteinuria in diabetic patients: decreases urinary albumin excretion, aiding renal preservation.

Common Side Effects: - Dizziness: may occur especially after the first dose. - Headache: mild to moderate intensity reported. - Fatigue: general feeling of tiredness. - Nausea: occasional gastrointestinal upset. - Hyperkalemia: elevated serum potassium levels. - Cough: dry or mild irritation of the throat.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips, tongue, or airway. - Acute renal failure: sudden decline in kidney function. - Hepatic injury: signs of liver dysfunction such as jaundice. - Severe hypotension: markedly low blood pressure causing dizziness or fainting.

Irbesartan should be used with careful monitoring in several clinical situations. - Monitor blood pressure: adjust therapy if target levels are not achieved. - Assess renal function: check serum creatinine and eGFR before and during treatment. - Check serum potassium: avoid hyperkalemia, especially with potassium‑sparing agents. - Use caution in severe hepatic impairment: dose adjustments may be required. - Avoid in pregnancy unless clearly needed: potential fetal harm. - Store at room temperature: keep in the original pack, protect from moisture.

Irbesartan may interact with several medicines that affect blood pressure, electrolytes, or renal function.

Major Interactions (Avoid): - ACE inhibitors or aliskiren in diabetic patients: increased risk of hyperkalemia and renal impairment. - Potassium‑sparing diuretics: additive hyperkalemia. - NSAIDs: may reduce antihypertensive effect and impair renal function. - Concomitant use with other ARBs: no added benefit and higher adverse‑event risk.

Moderate Interactions (Monitor Closely): - Lithium: may increase lithium levels, risking toxicity. - Cyclosporine: can raise serum creatinine. - Rifampin: may reduce irbesartan plasma concentrations. - Thiazide diuretics: may enhance hypotensive effect.